WO2006104656A1 - Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof - Google Patents
Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof Download PDFInfo
- Publication number
- WO2006104656A1 WO2006104656A1 PCT/US2006/008307 US2006008307W WO2006104656A1 WO 2006104656 A1 WO2006104656 A1 WO 2006104656A1 US 2006008307 W US2006008307 W US 2006008307W WO 2006104656 A1 WO2006104656 A1 WO 2006104656A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- formula
- aryl
- alkyl
- halide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 **(CCC123)C(C4)C1C=CCC2Oc1c3c4ccc1* Chemical compound **(CCC123)C(C4)C1C=CCC2Oc1c3c4ccc1* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Definitions
- the present invention relates to a method for the catalytic production of hydrocodone derivatives and hydromorphone derivatives.
- Hydrocodone and hydromorphone are opioid analgesics having similar qualities to codeine and morphine. Development of new opioid derivatives is desirable to produce new intermediates and potential sources of new analgesics. Conventional methods for producing hydrocodone and hydromorphone typically involve a two step oxidation/reduction route from codeine and morphine. Unfortunately, these methods are expensive and inefficient. Attempts to improve efficiency have included the use of catalytic methods. Known methods include the use of metallics, typically Ru, Rh, Pd and Pt on activated carbon as well as metallic complexes. The preparation of these catalysts is difficult, yields are poor, and isolation of the product is often burdensome.
- An aspect of the present invention is to provide a method for the catalytic conversion of a compound of Formula I into a compound of Formula II utilizing at least one transition metal complex as catalyst,
- R 1 is H, alkyl, aryl or acyl.
- Another aspect of the present invention is to provide a method for the catalytic conversion of a compound of Formula VI into a compound of Formula VII,
- R is selected from but not limited to H, a benzyl , a substituted benzyl , an alkyl, an aryl, an acyl, an aryl sulfonyl, an alkyl sulfonyl, a carboxyester, a carboxyamide, trialkylsilyl, tetrahydropyranyl and tetrahydrofuranyl group; and R 3 is selected from but not limited to H, an alkyl, an allyl, a cycloalkylalkyl, a benzyl, an aryl sulfonyl, an alkyl sulfonyl, an aryl, an acyl group, a formyl, a hydroxyl, a carboxyester and a carboxyamide.
- the transition metal complex is of the formula [M(PR 4 R 5 R 6 ) n X m ] p ; wherein M is a Group VHI transition metal; R 4 , R 5 and R 6 are selected from the group consisting of alkyl, aryl, alkoxyl, phenoxyl and combinations thereof; X is a halide or an anion; n is 1, 2, 3 or 4; m is 1 or 2; and p is at least 1.
- R 1 is H, alkyl, aryl or acyl.
- the method of the present invention is especially useful where R 1 is methyl or H, i.e., codeine or morphine, respectfully, leading to the formation of hydrocodone or hydromorphone, respectfully.
- R is selected from but not limited to H, a benzyl , a substituted benzyl , an alkyl, an aryl, an acyl, an aryl sulfonyl, an alkyl sulfonyl, a carboxyester, a carboxyamide, trialkylsilyl, tetrahydropyranyl and tetrahydrofuranyl group; and
- R 3 is selected from but not limited to H, an alkyl, an allyl, a cycloalkylalkyl, a benzyl, an aryl sulfonyl, an alkyl sulfonyl, an aryl, an acyl group, a formyl, a hydroxyl, a carboxyester and a carboxyamide.
- the method of the present invention can be utilized with quaternary salts as shown below:
- R 2 is selected from but not limited to H, a benzyl , a substituted benzyl , an alkyl, an aryl, an acyl, an aryl sulfonyl, an alkyl sulfonyl, a carboxyester, a carboxyamide, trialkylsilyl, tetrahydropyranyl and tetrahydrofuranyl group.
- R and R are independently selected from but not limited to H, an alkyl group, an allyl group, a benzyl group, an aryl group and an alkylenecycloalkane. Alternatively, R and R taken together form an oxide.
- Xi and X 2 are anions typically Cl or Br.
- X 1 and X 2 are anions independently selected from but not limited to BF 4 , PF 6 , ClO 4 , CHO 2 , C 2 O 4 , CF 3 CO 2 , CF 3 SO 3 , CH 3 CO 2 , ArCO 2 , CH 3 SO 3 , p-tolylSO 3 , HSO 4 and H 2 PO 4 or mixtures thereof, the products of anion exchange.
- Xj and X 2 are subject to exchange by the catalyst.
- the transition metal catalysts of the present invention comprise at least one transition metal complex of the formula [MXPR ⁇ R ⁇ n X ⁇ J p -, wherein, M is a Group VIE transition metal; R 4 , R 5 and R 6 are selected from the group consisting of alkyl, aryl, alkoxyl, phenoxyl and combinations; thereof, X is a halide or an anion; n is 1, 2, 3 or 4; m is 1 or 2; and p is at least 1;
- the transition metal catalysts of the present invention comprise a transition metal complex [M(PR 4 R 5 R 6 ) n X m ] p ; wherein, M is preferably a Group Vi ⁇ transition metal; R 4 , R 5 and R 6 are independently selected from alkyl, aryl, and alkoxyl, phenoxyl groups; X is a halide or an anion; n is 1, 2, 3 or 4; and m is 1 or 2. These complexes are capable of polymerizing, therefore p is at least 1. When all three of the R groups are alkoxyl, phenoxyl or combinations thereof, the ligand of the complex is termed a tertiary phosphite.
- the ligand of the complex is termed a tertiary phosphine.
- Preferred metals include Rh, Ru, Pd and Pt.
- the halide, X is typically Cl or Br.
- Anions include but are not limited to BF 4 , PF 6 , ClO 4 , CHO 2 , CaO 4 , CF 3 CO 2 , CF 3 SO 3 , CH 3 CO 2 , ArCO 2 , CH 3 SO 3 , p-tolylSO 3 , HSO 4 and H 2 PO 4 . Many of these catalysts are commercially available, or are easily prepared as is known in the art.
- the transition metal catalysts of the present invention comprise a transition metal complex of a tertiary phosphine halide, [M(PR 7 3 ) n X m ] p , wherein M is preferably a Group VIII transition metal; R 7 is an alkyl or aryl; X is a halide or an anion; n is 1, 2, 3 or 4; and m is 1 or 2.
- M is preferably a Group VIII transition metal
- R 7 is an alkyl or aryl
- X is a halide or an anion
- n 1, 2, 3 or 4
- m is 1 or 2.
- Preferred metals include Rh, Ru, Pd and Pt.
- the halide, X is typically Cl or Br.
- Anions include but are not limited to BF 4 , PF 6 , ClO 4 , CHO 2 , C 2 O 4 , CF 3 CO 2 , CF 3 SO 3 , CH 3 CO 2 , ArCO 2 , CH 3 SO 3 , p-tolylSO 3 , HSO 4 and H 2 PO 4 .
- R 7 is an alkyl or aryl group, with phenyl being preferred. Many of these catalysts are commercially available, or are easily prepared as is known in the art. It is noted that the catalysts of the formula [M(PR 7 3 ) n X m ]p are a subgroup of the broader group of catalysts [MCPR ⁇ R ⁇ n X ⁇ J p .
- the complexes of the present invention may be comprised of solid supported tertiary phosphines/phosphites, including but not limited to polymer supported tertiary phosphines/phosphites, silical supported tertiary phosphines/phosphites and resin-bound tertiary phosphines/phosphites.
- solid supported tertiary phosphines/phosphites one of the R groups typically contains a linking group connecting a phosphine/phosphite and a solid phase, as is well known in the art.
- a non-limiting example of a solid supported tertiary phosphine useful in the present invention is the copolymer prepared from the monomer p-styryldiphenylphosphine also known as diphenyl(p-vinylphenyl)phosphine with styrene or silical supported tertiary phosphines made from treating silica with (EtO) 3 SiCH 2 CH 2 PPh 2 .
- solid supported tertiary phosphines/phosphites that are commercially available.
- the metal is Rh and the complex is of the formula [Rh(PR 4 R 5 R 6 )nX ⁇ J P ; wherein R 4 , R 5 and R 6 are selected from the group consisting of alkyl, aryl, alkoxyl, phenoxyl and combinations thereof; X is a halide or an anion; n is 1, 2, 3 or 4; m is 1 or 2; and p is at least 1.
- the transition metal is Rh
- the metal complex is of the formula [Rh(PR 7 3 ) n X] p , wherein R 7 is an alkyl or aryl, X is a halide, n is 1, 2 or 3, and p is at least 1, or of the formula [Rh(PR 7 3 ) n Y] p , wherein R 7 is an alkyl or aryl, n is 1, 2 or 3, p is at least 1 and Y is an anion, preferably including BF 4 , PF 6 , ClO 4 , CHO 2 , CF 3 CO 2 , CF 3 SO 3 , CH 3 CO 2 , C 2 O 4 , Ai-CO 2 , CH 3 SO 3 , p-tolylSO 3 , HSO 4 or H 2 PO 4 .
- the transition metal is Ru and the metal complex is of the formula [Ru(PR 4 R 5 R 6 ) n X m ] p ; wherein R 4 , R 5 and R 6 are selected from the group consisting of alkyl, aryl, alkoxyl, phenoxyl and combinations thereof; X is a halide or an anion; n is 1, 2, 3 or 4; m is 1 or 2; and p is at least 1.
- a suitable method for producing an illustrative Ru complex of the present invention involves refluxing a Ru salt, for example RuCl 3 XH 2 O with an excess of triphenylphosphine in alcohol to form the complex [Ru(P(C 6 H 5 ) 3 ) 3 Cl 2 ] p .
- a Ru salt for example RuCl 3 XH 2 O
- triphenylphosphine in alcohol
- Rh complex of the present invention is also commercially available, or can be prepared by refluxing rhodium trichloride with triphenylphosphine in alcohol, typically methanol or ethanol.
- Rh-, Ru-, and/or Ir- complex can be bound to a tertiary copolymer of styrene, divinylbenzene, and diphenyl(p- vinylphenyl)phosphine also known as p-styryldiphenylphosphine, illustrated below:
- ethylene dimethacrylate ethylene dimethacrylate
- p-bromostyrene and crosslinking agents such as divinylbenzene, butadiene, diallyl maleate, diallyl phthalate, glycol dimethacrylate, and other di- or triolefins.
- Other phosphine containing monomers bound to the styrene ring can have, in addition to diaryl substitutions, dialkyl, branched and cyclic dialkyl, dialkoxyl or mixed substitutions or these.
- Illustrative examples utilizing styrene are shown in Formulas 18 and 19.
- the polymeric complex makes up a composition of matter consisting essentially of an intrinsically porous solid organic styrene-divinyl benzene copolymer; a substituent phosphine group chemically bonded through phosphorus to a carbon atom of said polymer; and a Group VIII metal chemically bonded to said substituent phosphine which composition is substantially insoluble in the solvent(s).
- the polymeric support is composed of a styrene divinylbenzene copolymer containing 2 to 20 mole percent divinylbenzene, in which 0.5 to 7 mole percent, preferably 5 to 6 mole percent of the pendant phenyl groups from the copolymerized styrene contain the diphenylphosphine moiety at the para position.
- the composition of the polymer support is 75 to 97.6 mole percent styrene, 2 to 20 percent divinylbenzene and 0.4 to 6 percent p-diphenylphosphenostyrene.
- the Ru/pendant atom ratio is preferably at least 0.001 and is more preferably about 0.5 to an upper limit set by the point at which the polymer support will no longer take up complex, for example about 1.2.
- the polymeric complex may be made by contacting a solution of the Group VIII metal salt complex in solution with the polymer support.
- the metal complex is dissolved in a suitable solvent including but not limited to water, methanol, ethanol, isopropanol, isobutyl alcohol, t-butyl alcohol, chloroform, dichloromethane, fluorobenzene, chlorobenzene, toluene, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, methyl sulfoxide, methyl sulfone, tetrahydrofuran and mixtures thereof.
- the Group V ⁇ I metal complex solution should be at least 10 ⁇ 6 M in the ruthenium complex but is preferably about 10 '3 M in the ruthenium complex.
- the polymer portion of the catalyst is intrinsically porous. Porosity of the polymer portion of the catalyst imparts increased activity to the catalyst. With catalysts having an organic polymer portion which is not intrinsically porous, porosity may be induced into the polymer portion by solvent swelling. Combinations of the above-noted solvents can be manipulated to produce various degrees of swelling of the polymer portion of the catalyst, as is well known in the art.
- the catalytic conversion of the present invention has the further economic advantage of being able to convert a salt of codeine or morphine, for example codeine hydrochloride or morphine hydrochloride, to hydrocodone, or hydromorphone, respectively.
- the catalysts of the present invention facilitate high value metal recovery of the metal containing solid catalyst.
- the metal of the present catalyst results in an improved recovery percentage. This further reduces material and labor costs, as well as simplifying processing/workup.
- recovery is meant to encompass recovery, recycling and/or regeneration of the metal.
- the catalyst/support can be placed in a column or container as part of a loop reactor.
- codeine in alcohol that is heated in a reactor can be pumped or gravity fed through a catalyst bed and cycled back to the reactor until the desired conversion to hydrocodone is produced.
- the advantages of this method include that many cycles (perhaps several batches) of product may be obtained with a given bed.
- the catalyst value is then easily recovered and sent back for reprocessing.
- the purification workup is simplified because the catalyst is not present in the solution. For practical reasons, the concentration of Group VJH metals must be below about 10 ppm in the product. On cooling, the product would crystallize out of solution in high purity, to be recovered by filtration or centrifugation.
- the reaction of the present invention may be accomplished by any conventional process.
- a suitable process includes dissolving the reactant of Formula I in a suitable solvent in a reaction vessel.
- Suitable solvents include but are not limited to alcohols, preferably primary and secondary lower alkyl alcohols.
- the reaction vessel is then flushed with an inert atmosphere, typically nitrogen.
- the catalyst is added and the reaction mixture is refluxed under the inert atmosphere until the conversion is essentially complete, typically at least about an hour.
- the reaction mixture is cooled and crystals of the product are collected.
- the product may be purified by recrystallization in a suitable solvent as is well known in the art, or by any other suitable conventional method of purification.
- a tertiary amine for example triethylamine, is added to the reaction mixture when the preferred Ru complex catalyst is used.
- the tertiary amine reduces the formation of side products, primarily the alkaloid neopine, a potential side product in reactions of the present invention utilizing the preferred Ru catalyst.
- the alkaloid compound is added to the reactants that form the catalyst and the catalyst formation reaction takes place in the presence of the alkaloid.
- the ability to form the catalyst and subsequently accomplish the catalytic conversion in the same reaction vessel further enhances the economy of the reaction.
- the flask was equipped with a condenser and nitrogen. The flask was flushed with nitrogen for five minutes with one neck opened. The catalyst, 0.50 g of RhCl(P(C 6 H 5 ) 3 ) 3 was added to the solution. The flask was then flushed with nitrogen for another five minutes, and the open neck was closed. The reaction mixture was stirred under nitrogen and heated to reflux for four hours, then cooled to O 0 C for 30 minutes. The resulting crystals were removed by filtration. The collected crystals were washed four times with 10ml cold methanol (5 0 C), and dried in air for one hour yielding pale yellow crystals (41.50 g, yield 83%). The filtrate was pumped down to dryness to give 6.14 g yellow solid.
- Morphine 50.00 g, was suspended in 500 ml methanol in a three neck flask equipped with condenser and nitrogen input and outlet. After refluxing under nitrogen for five minutes, one neck of the flask was opened. A catalyst, 0.50 g RhCl(P(C 6 H 5 ) S ) 3 -WaS added to the container. The opened neck was closed with a stopper. The reaction mixture was stirred under nitrogen and heated to reflux for 6 hours, cooled down to O 0 C for 30 minutes, and filtered. The collected solid was washed four times with cold methanol (5 0 C) and dried in air for 20 minutes.
- Ruthenium dimer was prepared by refluxing 1 g RuCl 3 XH 2 O with 3 equivalents P(C 6 HO 3 in EtOH (100 ml) overnight. The resulting catalyst, [Ru(P(C 6 H 5 ) 3 ) 2 Cl 2 ] 2 was obtained as a black precipitate after filtration, 63% yield.
- Example 3 The catalyst of Example 3 was reacted with codeine in MeOH in the presence of triethylamine in the ratios shown in the table below.
- the reaction mixtures were flushed with N 2 for 5 minutes, heated to reflux under N 2 , cooled to 0 0 C and filtered.
- the recovered crystals were washed twice with 5 ml MeOH and air dried to yield white crystals.
- Morphine, 1.0 g, and 80 mg [Ru(P(C 6 H 5 ) 3 ) 2 Cl 2 ] 2 was suspended in 10 ml MeOH. The reaction mixture was flushed with N 2 for 3 minutes, after which 0.25 ml triethylamine was added, and the mixture flushed with N 2 for another 3 minutes. The reaction mixture was heated to reflux with stirring under N 2 for 72 hours. The resulting solid was found to be hydromorphone.
- Codeine 50.00 g, is added to 200 ml methanol contained in a three necked flask equipped with condenser and nitrogen input and outlet. The mixture is taken to reflux under nitrogen. A polymer phosphine anchored Ru catalyst, 5 g (1 mole % Ru) is added to the container. The reaction mixture is stirred under nitrogen at reflux for several hours. An additional 800 ml of methanol is added and heating is continued for 30 minutes. The polymer catalyst is recovered for recycle by filtration of the hot liquor. About 800 ml of methanol is removed from the filtrate by distillation. The liquor is then cooled to O 0 C and maintained at that temperature for at least about 30 minutes.
- the product is collected by filtration, washed four times with cold methanol (5 0 C) and air dried. The product is placed under vacuum ( ⁇ 15 mm Hg) at room temperature for at least an hour. The product is obtained as a white powder weighing over 38 grams for a >75% yield. The purity and identity of the hydrocodone is confirmed by HPLC, H 1 and C 13 NMR and MS analyses.
- N-Codeine methobromide 50 g is dissolved in 200 ml methanol in a three-neck flask at room temperature.
- the flask is equipped with a condenser and nitrogen.
- the flask is flushed with nitrogen for five minutes with one neck opened.
- the catalyst, 0.50 g OfRhCl(P(C 6 Hs) 3 ) S is added to the solution.
- the flask is then flushed with nitrogen for another five minutes, and the open neck was closed.
- the reaction mixture is stirred under nitrogen and heated to reflux for six hours, then cooled.
- Methanol, 100 ml is removed by distillation. Ethyl acetate 100 ml is added and cooling is continued to -1O 0 C for one hour.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002602929A CA2602929A1 (en) | 2005-03-28 | 2006-03-07 | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof |
| EP06737475A EP1871774A1 (en) | 2005-03-28 | 2006-03-07 | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof |
| AU2006229734A AU2006229734A1 (en) | 2005-03-28 | 2006-03-07 | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof |
| JP2008504074A JP2008538746A (en) | 2005-03-28 | 2006-03-07 | Catalytic production of hydrocodone, hydromorphone and derivatives thereof |
| MX2007011752A MX2007011752A (en) | 2005-03-28 | 2006-03-07 | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66578405P | 2005-03-28 | 2005-03-28 | |
| US60/665,784 | 2005-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2006104656A1 true WO2006104656A1 (en) | 2006-10-05 |
Family
ID=36604198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2006/008307 Ceased WO2006104656A1 (en) | 2005-03-28 | 2006-03-07 | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1871774A1 (en) |
| JP (1) | JP2008538746A (en) |
| CN (1) | CN101151266A (en) |
| AU (1) | AU2006229734A1 (en) |
| CA (1) | CA2602929A1 (en) |
| MX (1) | MX2007011752A (en) |
| WO (1) | WO2006104656A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009003270A1 (en) * | 2007-06-29 | 2009-01-08 | Brock University | Methods for one-pot n-demethylation/n-acylation of morphine and tropane alkaloids |
| US8946214B2 (en) | 2011-05-06 | 2015-02-03 | Brock University | Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer |
| US8962841B2 (en) | 2007-06-29 | 2015-02-24 | Brock University | Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids |
| US9981978B2 (en) | 2013-07-24 | 2018-05-29 | Cambrex Charles City, Inc. | Preparation of saturated ketone morphinan compounds by catalytic isomerisation |
| WO2022101408A1 (en) | 2020-11-13 | 2022-05-19 | Ferrer Internacional, S.A. | Synthesis of hydromorphone base |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7231574B2 (en) * | 2020-02-27 | 2023-03-01 | 国立大学法人九州大学 | Novel porous crosslinked polymer, immobilized catalyst and device using the same |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998005667A1 (en) | 1996-08-01 | 1998-02-12 | Johnson Matthey Public Limited Company | Preparation of narcotic analgesics |
| WO2001034608A1 (en) * | 1999-11-09 | 2001-05-17 | Abbott Laboratories | Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
| US6440688B1 (en) * | 1996-10-29 | 2002-08-27 | Cambridge University Technical Services Limited | Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase |
| WO2005047291A1 (en) | 2002-11-11 | 2005-05-26 | Mallinckrodt Inc. | Method for the catalytic production of hydrocodone and hydromorphone |
| WO2005113557A1 (en) | 2003-11-05 | 2005-12-01 | Mallinckrodt, Inc. | Method for the catalytic production of hydrocodone and hydromorphone |
-
2006
- 2006-03-07 EP EP06737475A patent/EP1871774A1/en not_active Withdrawn
- 2006-03-07 CA CA002602929A patent/CA2602929A1/en not_active Abandoned
- 2006-03-07 JP JP2008504074A patent/JP2008538746A/en not_active Withdrawn
- 2006-03-07 WO PCT/US2006/008307 patent/WO2006104656A1/en not_active Ceased
- 2006-03-07 MX MX2007011752A patent/MX2007011752A/en active IP Right Grant
- 2006-03-07 CN CNA2006800103463A patent/CN101151266A/en active Pending
- 2006-03-07 AU AU2006229734A patent/AU2006229734A1/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998005667A1 (en) | 1996-08-01 | 1998-02-12 | Johnson Matthey Public Limited Company | Preparation of narcotic analgesics |
| US6440688B1 (en) * | 1996-10-29 | 2002-08-27 | Cambridge University Technical Services Limited | Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase |
| WO2001034608A1 (en) * | 1999-11-09 | 2001-05-17 | Abbott Laboratories | Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
| WO2005047291A1 (en) | 2002-11-11 | 2005-05-26 | Mallinckrodt Inc. | Method for the catalytic production of hydrocodone and hydromorphone |
| WO2005113557A1 (en) | 2003-11-05 | 2005-12-01 | Mallinckrodt, Inc. | Method for the catalytic production of hydrocodone and hydromorphone |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009003270A1 (en) * | 2007-06-29 | 2009-01-08 | Brock University | Methods for one-pot n-demethylation/n-acylation of morphine and tropane alkaloids |
| US7999104B2 (en) | 2007-06-29 | 2011-08-16 | Brock University | Methods for one-pot N-demethylation/N-acylation of morphine and tropane alkaloids |
| US8962841B2 (en) | 2007-06-29 | 2015-02-24 | Brock University | Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids |
| US9340550B2 (en) | 2007-06-29 | 2016-05-17 | Brock University | Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids |
| US8946214B2 (en) | 2011-05-06 | 2015-02-03 | Brock University | Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer |
| US9108967B2 (en) | 2011-05-06 | 2015-08-18 | Brock University | Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer |
| US9533993B2 (en) | 2011-05-06 | 2017-01-03 | Brock University | Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer |
| US9981978B2 (en) | 2013-07-24 | 2018-05-29 | Cambrex Charles City, Inc. | Preparation of saturated ketone morphinan compounds by catalytic isomerisation |
| WO2022101408A1 (en) | 2020-11-13 | 2022-05-19 | Ferrer Internacional, S.A. | Synthesis of hydromorphone base |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006229734A1 (en) | 2006-10-05 |
| MX2007011752A (en) | 2007-11-21 |
| EP1871774A1 (en) | 2008-01-02 |
| CN101151266A (en) | 2008-03-26 |
| CA2602929A1 (en) | 2006-10-05 |
| JP2008538746A (en) | 2008-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1687310B1 (en) | Method for the catalytic production of hydrocodone and hydromorphone | |
| US7321038B2 (en) | Method for the catalytic production of hydrocodone and hydromorphone | |
| WO2000032601A2 (en) | Process for preparing cross-bridged tetraaza macrocycles | |
| JP5532434B2 (en) | Organic-inorganic composite materials and uses thereof | |
| US7399858B2 (en) | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof | |
| AU2003290629B2 (en) | Method for the catalytic production of hydrocodone and hydromorphone | |
| Lustenberger et al. | Towards Asymmetric Catalysis in the Major Groove of 1, 1′‐Binaphthalenes | |
| EP1871774A1 (en) | Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof | |
| Fan et al. | Ring-Methyl Activation in Pentamethylcyclopentadienyl Complexes. 4. Syntheses, Structures, and Reactions of [(C5Me4CH2Cl) RuCl (CO) 2] and Related Compounds: X-ray Structures of [(C5Me4CH2Cl) RuCl (CO) 2] and [(C5Me4CH2OEt) Ru (PPh3)(CO) 2](OTf) | |
| AU2004319925B2 (en) | Method for the catalytic production of hydrocodone and hydromorphone | |
| EP1414566A1 (en) | Palladium catalysts | |
| CN118026834A (en) | Preparation method, synthetic intermediate and catalytic application of planar chiral indene metal complex with phenylindene skeleton | |
| US4076724A (en) | Polycyclic macrocyclic compounds | |
| Lomenzo et al. | Synthesis of (. eta. 5-C5Me5) Ru (. eta. 6-tryptamine)(CF3SO3) Complexes. Chemospecific. eta. 6 Coordination of the (. eta. 5-C5Me5) Ru+ Moiety | |
| MXPA06004973A (en) | Method for the catalytic production of hydrocodone and hydromorphone | |
| KR100275786B1 (en) | Silica gel supported bis-cinchona alkaloids, preparation method and use thereof | |
| US20100261905A1 (en) | Ruthenium Catalysts for the Production of Hydrocodone, Hydromorphone or a Derivative Thereof | |
| MXPA06004974A (en) | Method for the catalytic production of hydrocodone and hydromorphone | |
| WO2022223773A1 (en) | Mof, mof linkers and manufacturing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 200680010346.3 Country of ref document: CN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/011752 Country of ref document: MX |
|
| ENP | Entry into the national phase |
Ref document number: 2602929 Country of ref document: CA |
|
| ENP | Entry into the national phase |
Ref document number: 2008504074 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 4275/CHENP/2007 Country of ref document: IN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2006229734 Country of ref document: AU |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2006229734 Country of ref document: AU Date of ref document: 20060307 Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2006737475 Country of ref document: EP |










